Cumberland Pharmaceuticals (CPIX) Change in Cash (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Change in Cash of -$437448.0 for Q1 2026, up 84.68% on a YoY basis from -$236865.6 in Q1 2025, and up 88.34% sequentially from -$3.8 million in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Change in Cash (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of Change in Cash data on file, last reported at -$437448.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 84.68% year-over-year to -$437448.0; the trailing twelve-month figure through Mar 2026 stood at -$4.1 million (down 19.22% YoY), and the FY2025 full-year result was -$6.5 million, down 1723.94% from the prior year.
- Change in Cash grew to -$437448.0 in Q1 2026, from -$3.8 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $1.9 million in Q2 2023 to a low of -$9.8 million in Q1 2022.
- A 5-year average of -$943151.2 and a median of $128308.0 in 2024 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 666.9% in 2022, while the deepest fall reached 5879.04% in 2022.
- Tracing CPIX's Change in Cash over 5 years: stood at $216432.0 in 2022, then tumbled by 186.1% to -$186341.0 in 2023, then surged by 368.02% to $499430.0 in 2024, then sank by 851.27% to -$3.8 million in 2025, then soared by 88.34% to -$437448.0 in 2026.
- Business Quant data shows CPIX's Change in Cash at -$437448.0 in Q1 2026, -$3.8 million in Q4 2025, and -$890536.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -277.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Cumberland Pharmaceuticals | 106.37 Mn | 95.36 Mn | 7.20 Mn | -437,448.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -437,448.00 |
| Dec 31, 2025 | -3.75 Mn |
| Sep 30, 2025 | -890,536.00 |
| Jun 30, 2025 | 978,868.00 |
| Mar 31, 2025 | -2.86 Mn |
| Dec 31, 2024 | 499,430.00 |
| Sep 30, 2024 | 128,308.00 |
| Jun 30, 2024 | -1.21 Mn |
| Mar 31, 2024 | 226,861.00 |
| Dec 31, 2023 | -186,341.00 |
| Sep 30, 2023 | 258,879.00 |
| Jun 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | -3.37 Mn |
| Dec 31, 2022 | 216,432.00 |
| Sep 30, 2022 | 1.32 Mn |
| Jun 30, 2022 | 949,780.00 |
| Mar 31, 2022 | -9.77 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 172,769.00 |
| Jun 30, 2021 | 747,537.00 |